Alaunos Therapeutics (TCRT) Return on Equity [ROE] (2010 - 2026)
Alaunos Therapeutics (TCRT) recorded Return on Equity [ROE] of -418.35% in Q2 2026, down 247.30 percentage points from -171.05% a year earlier and down 180.68 percentage points from the prior quarter.
Alaunos Therapeutics (TCRT) Return on Equity [ROE] (2010 - 2026) Analysis & Trends
For FY2025, Alaunos Therapeutics reported Return on Equity [ROE] of -198.22%, down 83.24 percentage points from FY2024.
- Annual Return on Equity [ROE] has a five-year change of -124.83 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Equity [ROE] came in at -114.98% in FY2024 (+46.35 pp), -161.33% in FY2023 (-82.03 pp), -79.30% in FY2022 (+7.22 pp) and -86.52% in FY2021 (-13.13 pp).
- The Q2 2026 figure is the lowest quarterly Return on Equity [ROE] since Q2 2024.
- On a year-over-year basis, Return on Equity [ROE] rose in six of the last eight quarters, with an average year-over-year change of +71.13 percentage points.
- Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 284.57 percentage points in Q2 2025, against a drop of 378.75 percentage points in Q1 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at -237.67% (Q1 2026), -168.90% (Q4 2025) and -126.02% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Alaunos Therapeutics | 2.19 Mn | -1.61 Mn | - | -418.35% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -418.35% |
| Mar 31, 2026 | -237.67% |
| Dec 31, 2025 | -168.90% |
| Sep 30, 2025 | -126.02% |
| Jun 30, 2025 | -171.05% |
| Mar 31, 2025 | -266.77% |
| Dec 31, 2024 | -201.09% |
| Sep 30, 2024 | -369.73% |
| Jun 30, 2024 | -455.62% |
| Mar 31, 2024 | -493.56% |
| Dec 31, 2023 | -358.64% |
| Sep 30, 2023 | -212.14% |
| Jun 30, 2023 | -149.14% |
| Mar 31, 2023 | -114.81% |
| Dec 31, 2022 | -108.35% |
| Sep 30, 2022 | -112.51% |
| Jun 30, 2022 | -121.62% |
| Mar 31, 2022 | -124.97% |
| Dec 31, 2021 | -124.25% |
| Sep 30, 2021 | -114.30% |
Alaunos Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=TCRT&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "TCRT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=TCRT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();